Aromatase inhibitors, case study in late effects of, 97

Ashkenazi Jews, 101

Assessment tools, health care providers using, 5, 155

Association of American Medical Colleges (AAMC), 323, 455

Association of Cancer Online Resources (ACOR), 216, 242

Association of Community Cancer Centers (ACCC), 228–229

member cancer centers, 229

Association of Oncology Social Work (AOSW), 343, 414

Association of Professional Chaplains, 346

Assurances of privacy

HIPAA’s privacy rule, 456–457

of medical records, 454–457

Australia, 102

Autologous transplantation, 138

Availability barriers

faced by the uninsured in obtaining private individual insurance, 400

of individual market protections under HIPAA, 404

of state high-risk pools, 401

AVONCares Program, 413

B

Barriers faced by the uninsured in obtaining private individual insurance, 400

Barriers facing cancer survivors, 192–200

fragmented delivery system, 192–195

lack of awareness of the late effects of cancer and its treatment, 196–197

potential survivorship quality of care measures, 203

provision of counseling during adult cancer-related ambulatory care visits, United States, 2001-2002, 199

Barriers facing providers, 200–206

capacity for delivering survivorship care, 206–207

difficulties in communication, 203–206

fragmented delivery system hampering delivery of coordinated care, 200–201

lack of education and training, 201

lack of survivorship standards of care, 201–203

Barriers to communication, 197–200

Behavioral Research Center, 465

Bladder cancer, summary of articles describing recent U.S. surveillance practice patterns in, 272–273

Bladder dysfunction, 119–120

Bone damage, 139

Bowel dysfunction, 120

in colorectal cancer, 127

Brachytherapy, 114, 119–120

BRCA mutations, 477–478

Breast cancer. See also Female breast cancer

age distribution of incident and prevalent cases of, 52

end-of-treatment consultation notes for, 157–159

by race and ethnicity, age-standardized incidence and death rates for, 51

summary of articles describing recent U.S. surveillance practice patterns in, 254–259

survivors, compared to healthy controls, 86

trends in incidence, mortality, and survival, 49

Breast cancer clinical practice guidelines, 102–111

examples of breast cancer CPG recommendations on follow-up mammography, 112

examples of breast cancer CPG recommendations on menopausal symptom management, 113

Breast Cancer Surveillance Consortium (BCSC), 254

Business and Health, 382

C

Canada, 102

Cancer and Careers: Living and Working with Cancer, 241

Cancer and Menopause Study, 91

Cancer as a chronic disease. See also Chronic conditions

attitudes, 329

knowledge, 329

required objectives for medical school core curriculum, 329

skills, 329



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement